Inventor · disambiguated record
Larisa Reyderman
Also filed as: REYDERMAN LARISA
6 granted patents·9 pending applications·82 citations·filing 2007–2023
85Inventor score
Top patents by PatentIndex Score
15 records- 0195US11642347B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2020·Granted May 9, 2023·6 cites·10 claims
- 0291US10166238B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2015·Granted Jan 1, 2019·12 cites·19 claims
- 0391US7981905B2Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the sameOPKO HEALTH INC·Filed 2009·Granted Jul 19, 2011·24 cites·36 claims
- 0491US7563801B2Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the sameSCHERING CORP·Filed 2007·Granted Jul 21, 2009·23 cites·18 claims
- 0586US8404702B2Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the sameQIU ZHIHUI·Filed 2011·Granted Mar 26, 2013·14 cites·24 claims
- 0680US2024058348A1Ezh2 inhibitors for treating lymphomaEPIZYME INC·Filed 2023·Application pending·0 cites
- 0778US9345692B2Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the sameOPKO HEALTH INC·Filed 2013·Granted May 24, 2016·3 cites·5 claims
- 0863US2020022987A1Ezh2 inhibitors for treating lymphomaEPIZYME INC·Filed 2019·Application pending·0 cites
- 0961US2019175604A1Ezh2 inhibitors for treating lymphomaEPIZYME INC·Filed 2018·Application pending·0 cites
- 1056US2025051427A1Methods of using an anti-amyloid beta protofibril antibody and anti-tau antibodyEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 1154US2025377367A1Methods of treatment using p-tau181 levelEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 1254US2024352109A1Subcutaneous formulations of anti-abeta protofibril antibody and methods of use thereofEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 1352US2025163135A1Biomarkers for alzheimer's disease treatmentEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 1447US2012028976A1Pharmacokinetically-based dosing regiments of a thrombin receptor antagonistREYDERMAN LARISA·Filed 2009·Application pending·0 cites
- 1528US2012095052A1Par-1 antagonism in fed or antacid-dosed patientsREYDERMAN LARISA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Larisa Reyderman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →